DTYMK mouse monoclonal antibody, clone OTI1D2 (formerly 1D2)
| Applications | IF, WB |
| Reactivities | Human |
Products
Carrier-free (BSA/glycerol-free) DTYMK mouse monoclonal antibody, clone OTI1H4 (formerly 1H4)
| Applications | FC, IF, WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) DTYMK mouse monoclonal antibody, clone OTI2B1 (formerly 2B1)
| Applications | FC, IF, WB |
| Reactivities | Human |
DTYMK mouse monoclonal antibody, clone OTI1E12 (formerly 1E12)
| Applications | WB |
| Reactivities | Human |
DTYMK mouse monoclonal antibody, clone OTI1C4 (formerly 1C4), Biotinylated
| Applications | FC, IF, WB |
| Reactivities | Human |
DTYMK mouse monoclonal antibody, clone OTI1C4 (formerly 1C4), HRP conjugated
| Applications | FC, IF, WB |
| Reactivities | Human |
DTYMK mouse monoclonal antibody, clone OTI1G8 (formerly 1G8)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) DTYMK mouse monoclonal antibody, clone OTI1D2 (formerly 1D2)
| Applications | IF, WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) DTYMK mouse monoclonal antibody, clone OTI1E6 (formerly 1E6)
| Applications | IF, WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) DTYMK mouse monoclonal antibody, clone OTI2A1 (formerly 2A1)
| Applications | IF, WB |
| Reactivities | Human |
DTYMK mouse monoclonal antibody, clone OTI2B1 (formerly 2B1), HRP conjugated
| Applications | FC, IF, WB |
| Reactivities | Human |
DTYMK mouse monoclonal antibody, clone OTI1H4 (formerly 1H4), HRP conjugated
| Applications | FC, IF, WB |
| Reactivities | Human |
DTYMK mouse monoclonal antibody, clone OTI2B1 (formerly 2B1), Biotinylated
| Applications | FC, IF, WB |
| Reactivities | Human |
DTYMK mouse monoclonal antibody, clone OTI1H4 (formerly 1H4), Biotinylated
| Applications | FC, IF, WB |
| Reactivities | Human |
DTYMK (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
